Zinc protoporphyrin/heme as an indicator of iron status in NICU patients

Journal of Pediatrics

Volumn 142, Issue 3, 2003, Pages 273-278

  Juul, Sandra E ^a   Zerzan, Joan C ^a   Strandjord, Thomas P ^a   Woodrum, David E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS SULFATE; HEME; IRON; PROTOPORPHYRIN ZINC; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; CHILD GROWTH; CHORIOAMNIONITIS; GESTATIONAL AGE; GROWTH RETARDATION; HUMAN; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; NEWBORN; NEWBORN INTENSIVE CARE; NORMAL VALUE; PRIORITY JOURNAL; RETICULOCYTE COUNT; RISK FACTOR;

EID: 0037342240     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2003.101     Document Type: Article

References (32)

1. Dallman PR. Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr 1986;6:13-40.
2. Dallman PR. Manifestations of iron deficiency. Semin Hematol 1982;19:19-30.
3. Buonocore G, Perrone S, Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 2001;79:180-6.
4. Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion: iron load and retinopathy of prematurity. Eur J Pediatr 1997;156:465-70.
5. Dommergues MA, Gallego J, Evrard P, Gressens P. Iron supplementation aggravates periventricular cystic white matter lesions in newborn mice. Eur J Paediatr Neurol 1998;2:313-8.
6. Dani C, Reali MF, Bertini G, Martelli E, Pezzati M, Rubaltelli FF. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 2001;62:57-63.
7. Widdowson EM. Trace elements in foetal and early postnatal development. Proc Nutr Soc 1974;33:275-84.
8. Olivares M, Llaguno S, Marin V, Hertrampf E, Mena P, Milad M. Iron status in low-birth-weight infants, small and appropriate for gestational age: a follow-up study. Acta Paediatr 1992;81:824-8.
9. Iron fortification of infant formulas: American Academy of Pediatrics, Committee on Nutrition Pediatrics 1999;104:119-23.
10. Lackmann GM, Schnieder C, Bohner J. Gestational age-dependent reference values for iron and selected proteins of iron metabolism in serum of premature human neonates. Biol Neonate 1998;74:208-13.
11. Michaelsen KF, Milman N, Samuelson G. A longitudinal study of iron status in healthy Danish infants: effects of early iron status, growth velocity and dietary factors. Acta Paediatr 1995;84:1035-44.
12. Milman N, Ibsen KK, Christensen JM. Serum ferritin and iron status in mothers and newborn infants. Acta Obstet Gynecol Scand 1987;66:205-11.
13. Meyer JH, Meyer MP. Assessment of iron status in infants. Acta Paediatr 1995;84:1203.
14. Hastka J, Lasserre JJ, Schwarzbeck A, Reiter A, Hehlmann R. Laboratory tests of iron status: correlation or common sense? Clin Chem 1996;42:718-24.
15. Chisolm JJ Jr, Brown DH. Micromethod for zinc protoporphyrin in erythrocytes: including new data on the absorptivity of zinc protoporphyrin and new observations in neonates and sickle cell disease. Biochem Med 1979;22:214-37.
16. Hastka J, Lasserre JJ, Schwarzbeck A, Hehlmann R. Central role of zinc protoporphyrin in staging iron deficiency. Clin Chem 1994;40:768-73.
17. Labbe RF, Rettmer RL, Shah AG, Turnlund JR. Zinc protoporphyrin: past, present, and future. Ann N Y Acad Sci 1987;514:7-14.
18. Labbe RF, Vreman HJ, Stevenson DK. Zinc protoporphyrin: a metabolite with a mission. Clin Chem 1999;45:2060-72.
19. Lubchenco LO, Hansman C, Dressler M, Boyd E. Intrauterine growth as estimated from liveborn birth-weigh data at 24 to 42 weeks of gestation. Pediatrics 1963;32:793-800.
20. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference, I: definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997;157:715-25.
21. Gilstrap LC, Leveno KJ, Cox SM, Burris JS, Mashburn M, Rosenfeld CR. Intrapartum treatment of acute chorioamnionitis: impact on neonatal sepsis. Am J Obstet Gynecol 1988;159:579-83.
22. Labbé RF. Clinical utility of zinc protoporphyrin. Clin Chem 1992;38:2167-8.
23. Labbé RF. Zinc protoporphyrin/heme ratio as an indicator of marrow iron stores. Am J Clin Pathol 1991;95:758.
24. Labbé RF, Rettmer RL. Zinc protoporphyrin: a product of iron-deficient erythropoiesis. Semin Hematol 1989;26:40-6.
25. Rettmer RL, Carlson TH, Origenes ML, Jack RM, Labbé RF. Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency. Pediatrics 1999;104:e37.
26. Chockalingam UM, Murphy E, Ophoven JC, Weisdorf SA, Georgieff MK. Cord transferrin and ferritin values in newborn infants at risk for prenatal uteroplacental insufficiency and chronic hypoxia. J Pediatr 1987;111: 283-6.
27. Georgieff MK, Landon MB, Mills MM, Hedlund BE, Faassen AE, Schmidt RL, et al. Abnormal iron distribution in infants of diabetic mothers: spectrum and maternal antecedents. J Pediatr 1990;117:455-61.
28. Konijn AM, Hershko C. Ferritin synthesis in inflammation, I: pathogenesis of impaired iron release. Br J Haematol 1977;37:7-16.
29. Eckardt KU. Anemia in critical illness. Wien Klin Wochenschr 2001;113:84-9.
30. Winzerling JJ, Kling PJ. Iron-deficient erythropoiesis in premature infants measured by blood zinc protoporphyrin/heme. J Pediatr 2001;139: 134-6.
31. Bartels PC, Helleman PW, Soons JB. Changes in size and zinc protoporphyrin/haemoglobin ratio in red cells of infants during the first months of life. Ann Clin Biochem 1990;27:102-6.
32. Kilbride J, Baker TG, Parapia LA, Khoury SA. Incidence of iron-deficiency anaemia in infants in a prospective study in Jordan. Eur J Haematol 2000;64:231-6.